Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Filings indexed 1,047 across all filing types
Latest filing 2025-09-25 Regulatory Filings
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - NAN 4 pages 14.6KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Nanosonics Limited. It provides specific information about securities that have ceased, including the number, reason for cessation, and the date. The document is a formal announcement related to changes in the company's issued capital, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial data. It is not an annual or interim report, nor an earnings release or audit report. It is also not a report publication announcement since it contains substantive information about securities cessation. This type of document corresponds to a regulatory announcement about securities changes, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-09-25 English
Becoming a substantial holder 4 pages 919.8KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and is a 'Notice of initial substantial holder' under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Vanguard Group in Nanosonics Limited, including voting power, relevant interests, registered holders, consideration paid for shares, and associates. The document is a regulatory disclosure about a major shareholding notification, specifically reporting a substantial holder crossing a threshold of 5.159% voting power. It is not a financial report, earnings release, or management report, but a formal notification of share ownership changes as required by law. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and detail confirm it is the actual notification, not just an announcement or certification.
2025-09-24 English
Change of Director's Interest Notice 3 pages 223.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a change in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change (ordinary shares purchased on market), and other related information. This is a clear report of personal share transactions by a company director. The document length is 3624 characters, which is consistent with a detailed director's dealing notice. Therefore, this document fits the definition of 'Director's Dealing' (DIRS).
2025-09-21 English
Change to Non-Executive Director 1 page 121.4KB
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's board of directors, specifically the retirement of a non-executive director and the appointment of a new chair for a board committee. It does not contain financial data, regulatory filings, or report publications. The content clearly fits the category of Board/Management Information, as it relates to changes in the company's board members and management roles.
2025-09-04 English
Appendix 4E 4 pages 1.9MB
Regulatory Filings
2025-08-25 English
2025 Corporate Governance Statement 17 pages 403.7KB
Governance Information Classification · 95% confidence The document is titled 'Corporate Governance Statement' and discusses the company's governance principles, board roles and responsibilities, committee structures, director appointment processes, and policies related to governance. It references compliance with ASX Listing Rules and ASX Corporate Governance Principles. The content is focused on governance practices rather than financial results or operational performance. It is not an announcement or brief notice but a detailed governance report. Therefore, it fits the category of Governance Information (CGR). The document length (15,000 characters) supports it being a full governance statement rather than a short announcement or summary.
2025-08-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.